As a selective PDE5 inhibitor, Sildenafil operates through the NO/cGMP pathway to enhance erectile function. It prevents cGMP degradation, resulting in improved blood flow and smooth muscle relaxation. Initially investigated for angina by Pfizer, Sildenafil’s remarkable impact on ED led to its approval as Viagra in 1998. Known for efficacy and patient safety, it remains the primary option for those seeking ED treatment, and with over 20 million prescriptions worldwide, Viagra is the preferred choice, offering reliable, adaptable dosing to meet individual needs.
Dunzendorfer, U. (2012) Sildenafil. Switzerland: Birkhäuser Basel.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Viagra 50 by Gentech Laboratories, consult with your doctor or healthcare professional.
Dunzendorfer, U. (2012) Sildenafil. Switzerland: Birkhäuser Basel.
Dunzendorfer, U. (2012) Sildenafil. Switzerland: Birkhäuser Basel.
Dunzendorfer, U. (2012) Sildenafil. Switzerland: Birkhäuser Basel.